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Introduction
Candidiasis is a primary or secondary infection involving 
a member of the genus Candida. Essentially, this disease 
is an infection caused by Candida albicans. The clinical 
manifestations of the disease are extremely varied, rang-
ing from acute and/or chronic to episodic involvement 
probably localized to the mouth, throat, skin, scalp, bron-
chi, lungs, or the gastrointestinal tract or systemic as in 
septicemia, endocarditis, and meningitis. Since C. albicans 
is an endogenous species, the disease represents an oppor-
tunistic infection (1-3). 
Thymus vulgaris (Zataria multiflora) is a shrub plant in 
the family Lamiaceae. It is an aromatic and mountain herb 
which is commonly used as a spice to flavor food (4,5).
Recent studies suggest that the side effects of herbal drugs 
with significant therapeutic effects are far less than chemi-
cal drugs (6). Researches have shown that Z. multiflora is 
effective in treating many diseases, particularly in bacte-
rial and fungal infections and parasitic diseases (7).
Nigella sativa is from the order Ranunculales in the fam-
ily Ranunculaceae. This aromatic plant with tiny and dark 
seeds is usually used to flavor food such as bread. Nigella 
sativa is a plant from the buttercup family which grows as 
self-propelled in various parts of Europe and Asia includ-
ing Iran (8). 
In recent years much research has been done on the ef-
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Introduction: Candidiasis is a fungal infection caused by Candida albicans. Recent 
studies suggest that the side effects of herbal drugs with significant therapeutic effects 
are far less than chemical drugs. This study was therefore, conducted to examine 
antifungal activities of Zataria multiflora and Nigella sativa extracts on C. albicans. 
Methods: Powders of Z. multiflora and N. sativa were macerated with ethanol 70% and evaporated 
at 38˚C by rotary evaporator. The suspension of C. albicans was prepared according to McFarland 
at a concentration of approximately 0.5-2.5 × 103 CFU/ml. Testing was performed according to 
microbroth dilution in 96-well micro-dilution plates. Minimum inhibitory concentration (MIC), 
MIC50%, MIC90% and minimum fungicidal concentration (MFC) were separately evaluated by 
counting the fungal colonies for Z. multiflora and N. sativa.
Results: The measured values of MIC, MIC50%, MIC90% and MFC of Z. multiflora on the C. 
albicans were 0.13, 0.38, 0.74 and 1.03 mg/ml, and those of N. sativa were 10, 27.7, 52.3 and 72.3 mg/
ml, respectively.
Conclusion: The results indicate that both Zataria multiflora and Nigella sativa extracts are effective 
against Candida albicans, but the former species has the highest antifungal activity. If the clinical 
trials confirm the results of this study, Z. multiflora, as a new antifungal agent by replacing chemical 
drugs can be used to develop antifungal medicinal herbs.
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fectiveness of N. sativa extract including thymoquinone, 
thymohydroquinone, dithymoquinone, thymol and car-
vacrol, nigellicine, nigellimine-N-oxide, nigellidine and 
alpha-hedrine compounds (6).
Many reports have been published regarding several phar-
macological effects of N. sativa extract, some of which 
have been identified through application of modern tech-
niques, including antimicrobial activity of N. sativa oil 
(extract) and other through medicinal compounds such 
as thymoquinone and thymohydroquinone, on some bac-
teria including Staphylococcus aureus and particularly re-
cently on Pseudomonas aeruginosa, Both Escherichia coli 
and C. albicans. Thymoquinone have been reported to be 
effective on Aspergillus (7), and some opportunistic fungi 
which can cause mycotic infection in patients with AIDS 
and other immunodeficiency syndromes (7). This study 
was conducted to examine antifungal activities of Za-
taria multiflora and Nigella sativa extracts on C. albicans. 
Materials and Methods
To prepare extracts, Z. multiflora and N. sativa were pur-
chased from a reputable grocery and after separation of 
brushwood with an electric mill, they were pulverized. 
The resulting powder was passed through a No. 10 sieve 
and then poured into the flasks and mixed with 300 cc 
of 70% ethanol. The solution was kept for 72 hours in a 
dry environment. The solution was passed through the 
filter paper and then transferred into percolation system 
for extraction. At a temperature of 38°C of the system, the 
extract was transferred into the incubator with removing 
alcohol completely. Finally, various concentrations of the 
extracts were prepared using distilled water and 0.5 ml of 
dimethyl sulfoxide (9).
Preparation of C. albicans suspensions 
The standard fungal strain (code No. PTCC5027) used in 
this study was provided from Scientific Research Center 
of Iran. C. albicans was cultured on dextrose agar medium 
at 35°C. After 24 hours, some colonies were transferred to 
1 ml normal saline to prepare a solution with a concentra-
tion of 0.5 McFarland 1.5×106 CFU/ml (neobar slides were 
used for colony counting). The resulting solution was di-
luted to a ratio of 1:1000 and suspensions with concentra-
tions of (0.5-2.5)×103 CFU/ml were provided (10).
Preparation of Z. multiflora and N. sativa extracts
Different dilutions were prepared from Z. multiflora and 
N. sativa extracts using microbroth dilution according 
to the method proposed by the National Committee for 
Clinical Laboratory Standards for yeasts (NCCLSM27-A). 
Thus, two-fold dilution of the extract was poured into the 
first well of 96-well plates, and subsequent dilutions were 
prepared by serial dilution (10,11).
Different concentrations of the extracts prepared were as 
follows:
Z. multiflora: 0.093, 0.13, 0.185, 0.38, 0.5, 0.74, 1, 1.03, 
1.25, 1.5 mg/ml and N. sativa : 5, 10, 20, 30, 40, 50, 60 and 
70 mg/ml.
100 µl of each dilution of the extract was added separately 
to the socket of 96-well plates containing 100 ml of Sa-
bouraud broth liquid medium (Sabouraud broth). Then 
100 ml of yeast cell suspension in volumes equivalent to 
2500 cells/ml was inoculated into all the sockets, except 
the control plates. The plates were shaker-incubated at 
35°C for 48 hours. After incubation, 10 µl of the contents 
of each socket was cultured on Sabouraud dextrose agar 
medium and left for 48 hours at 35°C. After this period, 
minimum inhibitory concentration (MIC) and minimum 
fungicidal concentration (MFC) (CFU) were separately 
evaluated based on counting the fungal colonies for Z. 




The measured values of MIC, MIC50%, MIC90% and 
MFC of Z. multiflora extract on the C. albicans were 0.13, 
0.38, 0.74 and 1.03 mg/ml, respectively (Figure 1). 
N. sativa extract
The measured values of MIC, MIC50%, MIC90% and 



















Zataria multiflora extract 
Comparison the MIC and MFC Zataria multiflora 
extract on Candida albicans
Figure 1. Comparison of the minimum inhibitory concentration 
(MIC) and minimum fungicidal concentration (MFC) of Zataria 
multiflora extract on Candida albicans.
Figure 2. Comparison of the minimum inhibitory concentration 
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Comparison of inhibitory and fungicidal effects of extracts
The logistic regression test showed that there were sig-
nificant differences between the inhibitory and fungicidal 
effects of each of the plants extracts (P < 0.05). Z. multi-
flora had the highest inhibitory and fungicidal effects 
on C. albicans but N. sativa had the lowest antifungal ef-
fect (Figure 3). The measured values of MIC, MIC50%, 
MIC90% and MFC of Z. multiflora and N. sativa extracts 
are compared in Table 1.
Discussion
Candidiasis is a primary or secondary infection involving 
a member of the genus Candida. Essentially, this disease is 
an infection caused by C. albicans. The clinical manifes-
tations of the disease are varied, including acute, chronic 
and episodic involvement which is occasionally localized 
to the mouth, throat, skin, scalp, bronchi, lungs, or the 
gastrointestinal tract or systemic as in septicemia, endo-
carditis, and meningitis. Since C. albicans is an endoge-
nous species, the infection is opportunistic (1-3). 
Various studies have shown that many species of Candida 
have developed resistance to antifungal drugs. Nowadays 
traditional medicine and the use of herbal medicines to 
treat fungal infections are important because herbal medi-
cines have fewer side effects and are less likely to develop 
drug resistance compared with chemical ones (1-3).
Due to difficulties in treatment of candidiasis, it is neces-
sary to find new antifungal drugs. This increases the spec-
trum of antifungal drugs and eliminates the drug resistant 
strains. Herb plants can be beneficial for their therapeutic 
effects.
Akbari evaluated antifungal activities of Thymus vulgaris 
L. and Origanum vulgare L against fluconazol-resistant 
susceptible C. albicans isolates and found that the essence 
and extract of both plants were able to inhibit the growth 
of the isolates susceptible to fluconazole in a predictably 
concentration-dependent manner. The methanol extracts 
of Origanum had the highest antifungal effect with 0.49 
mg/ml MIC (13). In our study, the obtained MIC of Z. 
multiflora extract was 0.13 mg/ml for C. albicans, which 
is greater than the effect on C. albicans obtained for this 
extract in Akbari’s study. The contrasting results could be 
due to the different species of Z. multiflora, plant chemical 
compounds and/or methodologies.
In another study by Fuladi et al (14), the inhibitory effects 
of clotrimazole cream and herbal vaginal thyme cream 
were compared and the obtained MIC of Z. multiflora 
methanol and ethanol extracts were estimated to be 0.079 
and 0.125 mg/ml, respectively. 
Katiraei et al (15) compared the MIC of essential oils of 
Z. multiflora, Geranium and Artemisia with regard to the 
growth of the C. albicans isolates resistant to azole drugs. 
They showed that the MIC levels of essential oils of the 
plants were statistically significant from those of azoles. In 
that study, the obtained MIC of Z. multiflora for C. albi-
cans was 0.18 mg/ml.
The effect of alcoholic extract of thyme on the growth 
of Aspergillus was investigated and found that the use 
of plant extracts in food was useful for control of fungal 
growth without production of toxins in foods (16).
In another study performed by Gandomi Nasr Abadi et 
al (17), the effect of essential oils of Z. multiflora on As-
pergillus flavus was evaluated . It was found that all con-
centrations of oils had a significant effect on the growth 
and sporulation of A. flavus. Also, they reported the levels 
of MIC and MFC 400 and 1000 PPM, respectively. This 
extract has inhibitory effects on the mold and hence, it is 
recommended as alternatives to chemical preservatives in 
the food industry (17).
In a study by AL-Quarashi et al (18) on the antifungal 
activity of N. sativa extract (thymoquinone) against As-
pergillus niger and amphotericin b was investigated. It was 
found that the oil extract of N. sativa affected the growth 
of A. niger by 100% and could inhibit the growth of A. ni-
ger by 93.8%. The antifungal activity of N. sativa could be 
attributed to the thymoquinone.
To the best of our knowledge, No study has yet been con-
ducted to assess the MIC and minimum bactericidal con-
centration of N. sativa on C. albicans. Further studies will 
be needed to investigate antifungal activities of N. sativa. 
In our study, the obtained values of MIC, MIC50%, 
MIC90% and MFC of Z. multiflora extract on the C. al-
bicans were respectively 0.13, 0.38, 0.74 and 1.03 mg/ml, 
which are consistent with other studies. Therefore Z. mul-
tiflora extract has antifungal effect against C. albicans and 
can be used as an antifungal agent to treat fungal infec-
tions such as candidiasis.
In the present study, the obtained values of MIC, MIC50%, 
MIC90% and MFC of N. sativa were 10, 27.7, 52.3 and 72.3 
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Figure 3. Comparison of minimum inhibitory concentration (MIC), 
MIC50%, MIC90%, and minimum fungicidal concentration of 
Zataria multifora and Nigella sativa extracts on Candida albicans.
Table 1. MIC, MIC50%, MIC90% and MFC of Zataria multifora and 
Nigella sativa extracts on Candida albican (mg/ml)
Plant MIC MIC50% MIC90% MFC
Zataria multiflora 0.13* 0.38 0.74 1.03
Nigella sativa 10 27.7 52.3 72.3
Abbreviations: MIC, minimum inhibitory concentration; MFC, minimum 
fungicidal concentration. 
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tracts are able to inhibit the growth of C. albicans, but the 
former species has a greater impact on fungal infections. 
The major constituents of Z. multiflora are carvacrol, thy-
mol, and phenolic compounds with antifungal activities 
(5). In recent years much research has been done on the 
effectiveness of N. sativa extract including thymoquinone, 
thymohydroquinone, dithymoquinone, thymol and car-
vacrol compounds. It has been shown that the antifungal 
activity of N. sativa could be attributed to thymol and car-
vacrol contents (6).
Conclusion
In this study, antifungal effects of Z. multiflora and N. 
sativa extracts were determined for C. albicans. It was 
shown that, an increase in the concentration of plant ex-
tracts caused fungal growth inhibition. Antifungal drugs 
are expensive with side effects and harmful for patients 
which frequently lead to drug resistance. As herbal medi-
cines have fewer side effects and are less likely to develop 
drug resistance compared with chemical ones, they could 
be useful for treatment.
The results of the current study show that Z. multiflora 
extract plays a significant role in preventing of C. albicans 
growth. If the clinical trials confirm the results of this 
study Z. multiflora, as a new antifungal agent by replacing 
chemical drugs can be used to develop antifungal medici-
nal herbs. 
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